Home
>
National Drug Code (NDC)
>
Pepbis
Pepbis - 55651-264-01 - (Bismuth subslicylate)
Drug Information of Pepbis
| Product NDC: | 55651-264 |
| Proprietary Name: | Pepbis |
| Non Proprietary Name: | Bismuth subslicylate |
| Active Ingredient(s): | 17.5 mg/mL & nbsp; Bismuth subslicylate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Pepbis
| Product NDC: | 55651-264 |
| Labeler Name: | KC Pharmaceuticals, Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part335 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20040304 |
Package Information of Pepbis
| Package NDC: | 55651-264-01 |
| Package Description: | 237 mL in 1 BOTTLE (55651-264-01) |
NDC Information of Pepbis
| NDC Code | 55651-264-01 |
| Proprietary Name | Pepbis |
| Package Description | 237 mL in 1 BOTTLE (55651-264-01) |
| Product NDC | 55651-264 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Bismuth subslicylate |
| Dosage Form Name | SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20040304 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | KC Pharmaceuticals, Inc. |
| Substance Name | BISMUTH SUBSALICYLATE |
| Strength Number | 17.5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |
